Video Experimental Relacionado
Updated: Jul 16, 2026
12:01
Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
Published on: May 30, 2015
Mutación en el gen alfa-sinucleína identificada en familias con enfermedad de Parkinson
M H Polymeropoulos1, C Lavedan, E Leroy
1Laboratory of Genetic Disease Research, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892-1430, USA.
Science (New York, N.Y.)
|June 27, 1997
Resumen
Los investigadores identificaron una mutación específica del gen alfa-sinucleína vinculada a la enfermedad de Parkinson (EP) en casos familiares. Este descubrimiento ayuda a comprender los mecanismos subyacentes del trastorno neurodegenerativo.
Área de la Ciencia:
- La neurogenética es la neurogenética.
- Biología Molecular Biología Molecular
- Neurología Neurología.
Sus antecedentes:
- La enfermedad de Parkinson (EP) es un trastorno neurodegenerativo prevalente que afecta a aproximadamente el 2% de la población.
- Los patrones de agregación familiar sugieren un componente genético en la EP.
- Investigaciones anteriores localizaron un gen de susceptibilidad a la EP en el cromosoma 4 en una familia italiana.
Objetivo del estudio:
- Identificar la mutación genética específica responsable de la enfermedad de Parkinson en las familias afectadas.
- Para investigar el papel del gen alfa-sinucleína en la fisiopatología de la EP.
Principales métodos:
- Análisis del vínculo genético en una gran familia italiana.
- Cribado de mutaciones del gen alfa-sinucleína.
- Análisis de tres familias griegas no relacionadas con PD autosómica dominante.
Principales resultados:
- Se identificó una mutación en el gen alfa-sinucleína en el pariente italiano.
- La misma mutación se encontró en tres familias griegas no relacionadas con PD autosómica dominante.
- La alfa-sinucleína codifica una proteína presináptica implicada en la plasticidad neuronal.
Conclusiones:
- Una mutación específica del gen alfa-sinucleína está asociada con la enfermedad de Parkinson familiar.
- Este hallazgo proporciona una base molecular para la comprensión de la fisiopatología de la EP.
- La mutación identificada facilita una mayor investigación sobre los mecanismos de la enfermedad de Parkinson.
Videos de Conceptos Relacionados
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...